Literature DB >> 32279445

Synthesis, pharmacological evaluations, and molecular docking studies on a new 1,3,4,11b-tetrahydro-1H-fluoreno[9,1-cd]azepine framework: Rigidification of D1 receptor selective 1-phenylbenzazepines and discovery of a new 5-HT6 receptor scaffold.

Rajan Giri1,2, Ian Alberts3, Wayne W Harding1,2,4.   

Abstract

The novel 1,3,4,11b-tetrahydro-1H-fluoreno[9,1-cd]azepine framework, a structurally rigidified variant of the 1-phenylbenzazepine template, was synthesized via direct arylation as a key reaction. Evaluation of the binding affinities of the rigidified compounds across a battery of serotonin, dopamine, and adrenergic receptors indicates that this scaffold unexpectedly has minimal affinity for D1 and other dopamine receptors and is selective for the 5-HT6 receptor. The affinity of these systems at the 5-HT6 receptor is significantly influenced by electronic and hydrophobic interactions as well as the enhanced rigidity of the ligands. Molecular docking studies indicate that the reduced D1 receptor affinity of the rigidified compounds may be due in part to weaker H-bonding interactions between the oxygenated moieties on the compounds and specific receptor residues. Key receptor-ligand H-bonding interactions, salt bridges, and π-π interactions appear to be responsible for the 5-HT6 receptor affinity of the compounds. Compounds 10 (6,7-dimethoxy-2,3,4,11b-tetrahydro-1H-fluoreno[9,1-cd]azepine) and 12 (6,7-dimethoxy-2-methyl-2,3,4,11b-tetrahydro-1H-fluoreno[9,1-cd]azepine) have been identified as structurally novel, high affinity (Ki  = 5 nM), selective 5-HT6 receptor ligands.
© 2020 John Wiley & Sons A/S.

Entities:  

Keywords:  5-HT6; D1; benzazepine; docking; dopamine receptor; serotonin receptor

Mesh:

Substances:

Year:  2020        PMID: 32279445      PMCID: PMC7442682          DOI: 10.1111/cbdd.13691

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  28 in total

1.  Effects of chronic administration of the D1 receptor partial agonist SKF 77434 on cocaine self-administration in rhesus monkeys.

Authors:  Nicole H Mutschler; Jack Bergman
Journal:  Psychopharmacology (Berl)       Date:  2002-02-12       Impact factor: 4.530

2.  High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.

Authors:  Vadim Cherezov; Daniel M Rosenbaum; Michael A Hanson; Søren G F Rasmussen; Foon Sun Thian; Tong Sun Kobilka; Hee-Jung Choi; Peter Kuhn; William I Weis; Brian K Kobilka; Raymond C Stevens
Journal:  Science       Date:  2007-10-25       Impact factor: 47.728

3.  Differential effects of D1 and D2 dopamine agonists on stereotyped locomotion in rats.

Authors:  D Eilam; K V Clements; H Szechtman
Journal:  Behav Brain Res       Date:  1991-11-26       Impact factor: 3.332

4.  Dopamine D1/D5 receptor antagonists with improved pharmacokinetics: design, synthesis, and biological evaluation of phenol bioisosteric analogues of benzazepine D1/D5 antagonists.

Authors:  Wen-Lian Wu; Duane A Burnett; Richard Spring; William J Greenlee; Michelle Smith; Leonard Favreau; Ahmad Fawzi; Hongtao Zhang; Jean E Lachowicz
Journal:  J Med Chem       Date:  2005-02-10       Impact factor: 7.446

5.  Synthesis of C-Homoaporphines via Microwave-Assisted Direct Arylation.

Authors:  Sandeep Chaudhary; Wayne W Harding
Journal:  Tetrahedron       Date:  2011-01-21       Impact factor: 2.457

6.  Microwave-Assisted Direct Biaryl Coupling: First Application to the Synthesis of Aporphines.

Authors:  Sandeep Chaudhary; Stevan Pecic; Onica Legendre; Wayne W Harding
Journal:  Tetrahedron Lett       Date:  2009-05-20       Impact factor: 2.415

7.  Synthesis and receptor affinities of some conformationally restricted analogues of the dopamine D1 selective ligand (5R)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl- 1H-3-benzazepin-7-ol.

Authors:  J G Berger; W K Chang; J W Clader; D Hou; R E Chipkin; A T McPhail
Journal:  J Med Chem       Date:  1989-08       Impact factor: 7.446

Review 8.  Endogenous renal dopamine and control of blood pressure.

Authors:  C Bell
Journal:  Clin Exp Hypertens A       Date:  1987

9.  Synthesis and evaluation of 6,7-dihydroxy-2,3,4,8,9,13b-hexahydro-1H- benzo[6,7]cyclohepta[1,2,3-ef][3]benzazepine, 6,7-dihydroxy- 1,2,3,4,8,12b-hexahydroanthr[10,4a,4-cd]azepine, and 10-(aminomethyl)-9,10- dihydro-1,2-dihydroxyanthracene as conformationally restricted analogs of beta-phenyldopamine.

Authors:  S E Snyder; F A Aviles-Garay; R Chakraborti; D E Nichols; V J Watts; R B Mailman
Journal:  J Med Chem       Date:  1995-06-23       Impact factor: 7.446

10.  A new serotonin 5-HT6 receptor antagonist with procognitive activity - Importance of a halogen bond interaction to stabilize the binding.

Authors:  Juan A González-Vera; Rocío A Medina; Mar Martín-Fontecha; Angel Gonzalez; Tania de la Fuente; Henar Vázquez-Villa; Javier García-Cárceles; Joaquín Botta; Peter J McCormick; Bellinda Benhamú; Leonardo Pardo; María L López-Rodríguez
Journal:  Sci Rep       Date:  2017-01-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.